A robust in vitro screening assay to identify NF-κB inhibitors for inflammatory muscle diseases

International Immunopharmacology

Volumn 9, Issue 10, 2009, Pages 1209-1214

  Baudy, Andreas R ^a   Saxena, Nandita ^b   Gordish, Heather ^a   Hoffman, Eric P ^a   Nagaraju, Kanneboyina ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

C2C12 muscle cells; Duchenne Muscular Dystrophy; High throughput screening (HTS) assay; Inflammatory myopathy; Luciferase assay; NF B inhibitor

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; CELASTROL; FIBROBLAST GROWTH FACTOR; I KAPPA B; I KAPPA B KINASE INHIBITOR; I KAPPA B KINASE INHIBITOR II; I KAPPA B KINASE INHIBITOR VII; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREDNISOLONE; STEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WITHAFERIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; ENTERITIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; MYOBLAST; MYOSITIS; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SCREENING;

ANIMALS; CELL LINE; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; MICE; MUSCLE, SKELETAL; MYOSITIS; NF-KAPPA B; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949175349     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.07.001     Document Type: Article

References (22)

1. Monici M.C., Aguennouz M., Mazzeo A., Messina C., and Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne Muscular Dystrophy. Neurology 60 (2003) 993-997
2. Nagaraju K., Casciola-Rosen L., Lundberg I., Rawat R., Cutting S., Thapliyal R., et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheumatol 52 (2005) 1824-1835
3. Chen Y.W., Nagaraju K., Bakay M., McIntyre O., Rawat R., Shi R., et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne Muscular Dystrophy. Neurology 65 (2005) 826-834
4. Cai D., Frantz J.D., Tawa Jr. N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKBeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119 2 (2004) 285-298
5. Nagaraju K. Immunological capabilities of skeletal muscle cells. Acta Physiol Scand 171 (2001) 215-223
6. Sarabia V., Ramlal T., and Klip A. Glucose uptake in human and animal muscle cells in culture. Biochem Cell Biol 68 (1990) 536-542
7. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of nf-kappa B activity through induction of I kappa B synthesis. Science 270 (Oct 13 1995) 286-290
8. Manzur A.Y., Kuntzer T., Pike M., and Swan A. Glucocorticoid corticosteroids for Duchenne Muscular Dystrophy. Cochrane Database Syst Rev 1 (2008) CD003725
9. Seshadri R., Feldman B.M., Ilowite N., Cawkwell G., and Pachman L.M. The role of aggressive corticosteroid therapy in patients with juvenile dematomyositis: a propensity score analysis. Arthritis Rheumatol 59 (2008) 989-995
10. Sethi G., Ahn K.S., Pandey M.K., and Aggarwal B.B. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 109 (2007) 2727-2735
11. Jin H.Z., Hwang B.Y., Kim H.S., Lee J.H., Kim Y.H., and Lee J.J. Antiinflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production. J Nat Prod 65 (2002) 89-91
12. Li H., Zhang Y.Y., Tan H.W., Jia Y.F., and Li D. Therapeutic effect of tripterine on adjuvant arthritis in rats. J Enthnopharmacol 118 (2008) 479-484
13. Waelchli R., Bollbuck B., Bruns C., Buhl T., Eder J., Feifel R., et al. Design and preparation of 2-benzamido-pyrmidines as inhibitors of IKK. Bioorg Med Chem Lett 16 (2005) 108-112
14. Iyer S.N., Hyde D.M., and Giri S.N. Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation. Inflammation 24 (2000) 477-491
15. Nakazato H., Oku H., Yamane S., Tsuruta Y., and Suzuki R. A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level. Eur J Pharmacol 446 (2002) 177-185
16. Van Erp C., Irwin N.G., and Hoey A.J. Long-term administration of pirfenidone improves cardiac function in mdx mice. Muscle Nerve 34 (2006) 327-334
17. Lin R.W., Chen C.H., Wang Y.H., Ho M.L., Hung S.H., Chen I.S., et al. (-)-Epigallocatchin gallate inhibition of osteoclastic differentiation via NF-kappaB. Biochem Biophys Res Commun 379 (2009) 1003-1007
18. Nakae Y., Hirasaka K., Goto J., Nikawa T., Shono M., Yoshida M., et al. Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study. Histochem Cell Biol 129 (2008) 489-501
19. Huff T., Müller C.S., Otto A.M., Netzker R., and Hannappel E. beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33 (2001) 205-220
20. Lungu G., Covaleda L., Mendes O., Martini-Stoica H., and Stoica G. FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1. Mol Carcinog 47 (2008) 424-435
21. Singh D., Aggarwal A., Maurya R., and Naik S. Withania somnifera inhibits NF-kappab and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother Res 21 (2007) 905-913
22. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272 (1997) 21096-21103